Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SHPH | US
0.05
5.89%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
24/03/2026
0.94
0.87
0.96
0.85
Shuttle Pharmaceuticals Holdings Inc. a clinical stage pharmaceutical company develops novel therapies to cure cancers. It develops Ropidoxuridine an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161 an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225 a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303 a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville Maryland.
View LessPrice Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
87.9%1 month
85.5%3 months
140.4%6 months
128.3%-
-
4.37
1.44
0.41
-0.67
-
-
-5.74M
2.76M
2.76M
-
-
-
-
-186.00
0.03
1.94
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.21
Range1M
0.32
Range3M
3.64
Rel. volume
0.69
Price X volume
47.94K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 0.802 | 2.29M | -3.96% | n/a | -104.44% |
| Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 0.15 | 1.84M | 1.00 | 27.85% | |
| Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 0.5996 | 1.36M | -7.30% | n/a | 222.75% |
| Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0004 | 439.55K | n/a | -22.64% | |
| Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.057 | 145.47K | n/a | 4.26% | |
| PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.0072 | 69.17K | 0.00% | n/a | 83.11% |
| Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.0851 | 0 | 0.00% | n/a | 2.46% |
| CURE Pharmaceutical Holding Corp | CURR | Drug Manufacturers-Specialty & Generic | 2.47 | 0 | 1.65% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.055 | 1.13M | -3.52% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.007 | 645.50K | 0.00% | n/a | -37.05% |
| Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 12.8 | 0 | 0.27% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.67 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 30.05 | - |
| Price to Book | 4.37 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 140.40 | - | Riskier |
| Debt to Equity | 1.44 | -1.88 | Expensive |
| Debt to Assets | 0.41 | 0.48 | Par |
| Market Cap | 2.76M | - | Emerging |